Business Description
Based in Shanghai, People's Republic of China, 111, Inc. (established in 2010 and formerly known as New Peak Group until April 2018) is a prominent entity in the Chinese healthcare sector, operating a comprehensive online-to-offline (O2O) ecosystem. Its operations are structured across both business-to-business (B2B) and business-to-consumer (B2C) channels. The company facilitates the sale of a wide array of medical and wellness products, reaching customers through its online retail channels as well as wholesale and retail pharmacy networks. This extensive product catalog encompasses prescription medications, over-the-counter drugs (both Western and traditional Chinese), dietary supplements like vitamins, optical products such as contact lenses, various medical supplies and devices (e.g., bandages, thermometers), personal care items (including skincare, birth control, and sexual wellness products), and infant care essentials. Beyond product sales, 111, Inc. provides value-added services to consumers, such as online consultation and electronic prescription fulfillment. For its business partners, the company manages an online marketplace enabling third-party vendors to directly supply pharmacies. It further supports its "1 Pharmacy" clients – comprising pharmacies and wholesalers – with online loan application services, alongside offering data and supply chain integration solutions. Its operational scope also extends to critical back-end functions, including warehousing, logistics management, procurement, research and development, consulting, as well as software development and IT support. As of December 31, 2021, its physical footprint included 14 retail pharmacies operating under the "Yi Hao Pharmacy" brand across several key regions: Guangzhou, Tianjin, Kunshan, Chongqing, and Wuhan. The company caters to a diverse clientele, encompassing individual consumers, pharmacies, pharmaceutical manufacturers and distributors, medical practitioners, and insurance providers.
Business History
Price History (1 Year)
Key Metrics
EPS (Diluted): N/A
Total Equity: N/A
Shares: N/A
Total Debt: $0.00
Cash: $0.00
EBITDA: N/A
Total Debt: $0.00
Cash: $0.00
Revenue: N/A
Shares: N/A
Revenue: N/A
Revenue: N/A
Revenue: N/A
Total Equity: N/A
Tax Rate: N/A
Equity: N/A
Total Debt: $0.00
Cash: $0.00
Current Liabilities: N/A
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: N/A
Shares: N/A
Shares: N/A
CapEx: $0.00
Shares: N/A
Stock Price: $4.08
Net Income: N/A
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement
Requires paid FMP plan for this ticker
Analyst Estimates (Annual)
Last updated: Jun 27, 2026 3:14am (5h ago)| Metric | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| Revenue |
$14.5B $14.5B – $14.5B
|
$15.5B $15.5B – $15.5B
|
$17.7B $17.7B – $17.7B
|
$20.4B $20.4B – $20.4B
|
| EBITDA |
-$261.5M -$261.5M – -$261.5M
|
-$279.4M -$279.4M – -$279.4M
|
-$319.5M -$319.5M – -$319.5M
|
-$366.9M -$366.9M – -$366.9M
|
| Net Income |
$212.2M $212.2M – $212.2M
|
$0 | $0 | $0 |
| EPS | — | — | — | — |
Insider Trading (Recent)
Last updated: Jun 27, 2026 3:14am (5h ago)All SEC Form 4 codes
- P Purchase
- Open-market or private purchase of shares.
- S Sale
- Open-market or private sale of shares.
- A Award / grant
- Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
- D Return to issuer
- Securities disposed back to the company under Rule 16b-3.
- F In-kind (tax)
- Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
- I Discretionary
- Discretionary transaction under an employee plan — Rule 16b-3(f).
- M Option exercise
- Exercise or conversion of a derivative (option/RSU) into shares — exempt.
- C Conversion
- Conversion of a derivative security into the underlying shares.
- E Short expiration
- Expiration of a short derivative position.
- H Long expiration
- Expiration or cancellation of a long derivative position with value received.
- O OTM exercise
- Exercise of an out-of-the-money derivative.
- X ITM exercise
- Exercise of an in-the-money or at-the-money derivative.
- G Gift
- Bona fide gift of securities.
- L Small acquisition
- Small acquisition under Rule 16a-6.
- W Inheritance
- Acquisition or disposition by will or the laws of descent.
- Z Voting trust
- Deposit into or withdrawal from a voting trust.
- J Other
- Other acquisition or disposition (explained in a Form 4 footnote).
- K Equity swap
- Transaction in an equity swap or similar instrument.
- U Tender / buyout
- Disposition via tender of shares in a change-of-control transaction.
Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Chen Yang Luke | S-Sale | 49,920.00 | $0.23 | $11,482 |
| 2026-06-15 | Chen Yang Luke | S-Sale | 44,000.00 | $0.23 | $10,120 |
| 2026-06-15 | Sun Jian David | S-Sale | 58,800.00 | $0.23 | $13,524 |
| 2026-06-11 | Sun Jian David | S-Sale | 111,100.00 | $0.23 | $25,553 |
| 2026-06-09 | Sun Jian David | S-Sale | 12,000.00 | $0.23 | $2,760 |
| 2026-06-10 | Sun Jian David | S-Sale | 115,440.00 | $0.22 | $25,397 |
| 2026-05-12 | Luo Jun Justin | A-Award | 413,168.00 | $0.00 | $0 |
| 2026-05-26 | Luo Jun Justin | S-Sale | 29,280.00 | $0.27 | $7,906 |
| 2026-05-27 | Luo Jun Justin | S-Sale | 70,440.00 | $0.25 | $17,610 |
| 2026-05-11 | Luo Jun Justin | A-Award | 378,737.00 | $0.00 | $0 |
| 2018-09-12 | Luo Jun Justin | A-Award | 18,366.00 | $0.00 | $0 |
| 2026-05-12 | Sun Jian David | A-Award | 413,168.00 | $0.00 | $0 |
| 2026-05-26 | Sun Jian David | S-Sale | 29,280.00 | $0.27 | $7,906 |
| 2026-05-27 | Sun Jian David | S-Sale | 70,440.00 | $0.25 | $17,610 |
| 2026-05-11 | Sun Jian David | A-Award | 378,737.00 | $0.00 | $0 |
| 2018-09-12 | Sun Jian David | A-Award | 18,366.00 | $0.00 | $0 |
| 2026-05-12 | Chen Yang Luke | A-Award | 413,168.00 | $0.00 | $0 |
| 2026-05-26 | Chen Yang Luke | S-Sale | 1,440.00 | $0.27 | $389 |
| 2026-05-27 | Chen Yang Luke | S-Sale | 3,400.00 | $0.25 | $850 |
| 2026-05-11 | Chen Yang Luke | A-Award | 54,759.00 | $0.00 | $0 |
Narrative Economics
market-narrative step).